| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis | 41 | 2024 | 1072 | 6.120 |
Why?
|
| Gene Transfer Techniques | 90 | 2024 | 1207 | 5.400 |
Why?
|
| Cartilage, Articular | 79 | 2025 | 1104 | 5.200 |
Why?
|
| Bone Morphogenetic Protein 2 | 33 | 2023 | 344 | 4.400 |
Why?
|
| Genetic Vectors | 103 | 2024 | 3402 | 3.610 |
Why?
|
| Chondrocytes | 35 | 2025 | 800 | 3.400 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 41 | 2024 | 299 | 3.200 |
Why?
|
| Wound Healing | 41 | 2023 | 2808 | 3.090 |
Why?
|
| Adenoviridae | 58 | 2020 | 1092 | 2.980 |
Why?
|
| Bone Regeneration | 15 | 2023 | 443 | 2.970 |
Why?
|
| Synovial Membrane | 48 | 2009 | 536 | 2.660 |
Why?
|
| Interleukin-1 | 54 | 2016 | 1252 | 2.480 |
Why?
|
| Arthritis | 26 | 2018 | 684 | 2.460 |
Why?
|
| Fracture Healing | 22 | 2022 | 448 | 2.370 |
Why?
|
| Arthritis, Rheumatoid | 45 | 2024 | 3781 | 2.320 |
Why?
|
| Tissue Engineering | 20 | 2019 | 1893 | 2.290 |
Why?
|
| Sialoglycoproteins | 32 | 2006 | 316 | 2.270 |
Why?
|
| Regenerative Medicine | 8 | 2020 | 313 | 2.220 |
Why?
|
| Transduction, Genetic | 32 | 2023 | 899 | 2.100 |
Why?
|
| Achilles Tendon | 10 | 2022 | 181 | 2.050 |
Why?
|
| Bone Morphogenetic Proteins | 24 | 2018 | 845 | 2.040 |
Why?
|
| Orthopedics | 14 | 2021 | 906 | 1.910 |
Why?
|
| Transforming Growth Factor beta | 34 | 2022 | 1996 | 1.900 |
Why?
|
| Osteogenesis | 22 | 2023 | 1288 | 1.870 |
Why?
|
| Transforming Growth Factor beta1 | 14 | 2020 | 638 | 1.820 |
Why?
|
| Bone and Bones | 18 | 2022 | 2589 | 1.580 |
Why?
|
| Rabbits | 93 | 2009 | 4771 | 1.570 |
Why?
|
| Bone Diseases | 9 | 2018 | 416 | 1.540 |
Why?
|
| Nitric Oxide | 26 | 2004 | 2146 | 1.540 |
Why?
|
| Mesenchymal Stem Cells | 23 | 2020 | 1672 | 1.360 |
Why?
|
| Chondrogenesis | 14 | 2020 | 239 | 1.330 |
Why?
|
| Musculoskeletal Diseases | 9 | 2012 | 599 | 1.250 |
Why?
|
| Injections, Intra-Articular | 27 | 2024 | 284 | 1.240 |
Why?
|
| Tendons | 14 | 2022 | 556 | 1.230 |
Why?
|
| Proteoglycans | 25 | 2007 | 809 | 1.210 |
Why?
|
| Retroviridae | 27 | 2018 | 846 | 1.200 |
Why?
|
| Joint Diseases | 8 | 2013 | 461 | 1.120 |
Why?
|
| Fractures, Bone | 12 | 2022 | 2062 | 1.080 |
Why?
|
| Animals | 241 | 2025 | 169222 | 1.030 |
Why?
|
| Joints | 9 | 2019 | 324 | 1.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2018 | 1656 | 1.000 |
Why?
|
| Receptors, Interleukin-1 | 19 | 2005 | 260 | 1.000 |
Why?
|
| Regeneration | 10 | 2018 | 1524 | 0.990 |
Why?
|
| Tendon Injuries | 7 | 2022 | 329 | 0.990 |
Why?
|
| Femur | 11 | 2023 | 1321 | 0.900 |
Why?
|
| Metalloendopeptidases | 17 | 1997 | 386 | 0.890 |
Why?
|
| DNA, Complementary | 13 | 2012 | 1989 | 0.880 |
Why?
|
| Dependovirus | 9 | 2024 | 720 | 0.880 |
Why?
|
| Awards and Prizes | 2 | 2024 | 365 | 0.860 |
Why?
|
| Transgenes | 21 | 2018 | 1016 | 0.840 |
Why?
|
| Synovial Fluid | 14 | 2022 | 393 | 0.840 |
Why?
|
| Arthritis, Experimental | 12 | 2012 | 293 | 0.830 |
Why?
|
| Collagen | 25 | 2018 | 2641 | 0.820 |
Why?
|
| Fibroblast Growth Factor 2 | 6 | 2018 | 590 | 0.790 |
Why?
|
| Cells, Cultured | 74 | 2024 | 19017 | 0.740 |
Why?
|
| Diaphyses | 1 | 2020 | 65 | 0.710 |
Why?
|
| Musculoskeletal System | 4 | 2015 | 188 | 0.710 |
Why?
|
| Rheumatic Diseases | 4 | 2013 | 659 | 0.710 |
Why?
|
| Rats | 41 | 2023 | 23751 | 0.690 |
Why?
|
| Recombinant Proteins | 26 | 2023 | 6515 | 0.680 |
Why?
|
| Growth Substances | 14 | 2005 | 759 | 0.680 |
Why?
|
| Tacrolimus | 2 | 2021 | 750 | 0.680 |
Why?
|
| Muscle, Skeletal | 9 | 2017 | 4978 | 0.660 |
Why?
|
| Metacarpophalangeal Joint | 6 | 2009 | 82 | 0.640 |
Why?
|
| Cartilage | 15 | 2020 | 811 | 0.640 |
Why?
|
| Biocompatible Materials | 4 | 2017 | 1702 | 0.640 |
Why?
|
| RNA | 2 | 2019 | 2718 | 0.630 |
Why?
|
| Cytokines | 30 | 2022 | 7450 | 0.630 |
Why?
|
| Durapatite | 2 | 2017 | 167 | 0.630 |
Why?
|
| Spinal Diseases | 6 | 2013 | 561 | 0.630 |
Why?
|
| Lac Operon | 19 | 2001 | 237 | 0.620 |
Why?
|
| Gene Expression | 47 | 2017 | 7597 | 0.620 |
Why?
|
| Dinoprostone | 18 | 2004 | 597 | 0.610 |
Why?
|
| Serum | 2 | 2016 | 206 | 0.580 |
Why?
|
| Microbial Collagenase | 14 | 1991 | 112 | 0.580 |
Why?
|
| Anterior Cruciate Ligament | 10 | 2011 | 423 | 0.570 |
Why?
|
| Insulin-Like Growth Factor I | 16 | 2009 | 1942 | 0.570 |
Why?
|
| Dexamethasone | 5 | 2024 | 1964 | 0.560 |
Why?
|
| Cell Differentiation | 19 | 2020 | 11665 | 0.560 |
Why?
|
| Biological Therapy | 2 | 2016 | 140 | 0.550 |
Why?
|
| omega-N-Methylarginine | 10 | 2000 | 108 | 0.550 |
Why?
|
| Rheumatology | 3 | 2010 | 617 | 0.550 |
Why?
|
| Fibroblasts | 35 | 2010 | 4176 | 0.550 |
Why?
|
| Menisci, Tibial | 4 | 2007 | 267 | 0.540 |
Why?
|
| Chitosan | 2 | 2017 | 141 | 0.530 |
Why?
|
| Humans | 224 | 2025 | 767991 | 0.500 |
Why?
|
| Osteoblasts | 5 | 2019 | 1145 | 0.490 |
Why?
|
| Clinical Trials as Topic | 22 | 2018 | 8052 | 0.490 |
Why?
|
| Platelet-Rich Plasma | 2 | 2018 | 180 | 0.480 |
Why?
|
| Nitric Oxide Synthase | 12 | 2000 | 911 | 0.480 |
Why?
|
| Glycoproteins | 5 | 2011 | 2201 | 0.470 |
Why?
|
| Horses | 16 | 2023 | 294 | 0.460 |
Why?
|
| Femoral Fractures | 5 | 2012 | 376 | 0.450 |
Why?
|
| Glucocorticoids | 4 | 2024 | 2166 | 0.450 |
Why?
|
| Penicillamine | 6 | 2000 | 60 | 0.450 |
Why?
|
| Cartilage Diseases | 4 | 2018 | 160 | 0.440 |
Why?
|
| Ligaments | 4 | 2014 | 127 | 0.440 |
Why?
|
| Tetradecanoylphorbol Acetate | 10 | 1997 | 826 | 0.440 |
Why?
|
| Rats, Inbred F344 | 6 | 2020 | 826 | 0.430 |
Why?
|
| Arginine | 9 | 2013 | 932 | 0.420 |
Why?
|
| Contusions | 1 | 2013 | 78 | 0.420 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2011 | 130 | 0.420 |
Why?
|
| Tissue Scaffolds | 2 | 2022 | 950 | 0.420 |
Why?
|
| Interleukin-10 | 9 | 2004 | 1183 | 0.410 |
Why?
|
| Models, Animal | 13 | 2018 | 2120 | 0.410 |
Why?
|
| Extracellular Matrix Proteins | 7 | 2011 | 832 | 0.410 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2021 | 8120 | 0.400 |
Why?
|
| Knee Injuries | 5 | 1997 | 495 | 0.400 |
Why?
|
| Extracellular Matrix | 7 | 2025 | 1739 | 0.400 |
Why?
|
| Muscular Diseases | 1 | 2016 | 553 | 0.400 |
Why?
|
| Adenoviruses, Human | 5 | 2001 | 257 | 0.380 |
Why?
|
| Orthopedic Procedures | 3 | 2011 | 1279 | 0.380 |
Why?
|
| Losartan | 1 | 2013 | 262 | 0.380 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2013 | 507 | 0.370 |
Why?
|
| Tissue Transplantation | 2 | 2009 | 128 | 0.370 |
Why?
|
| RNA, Messenger | 26 | 2023 | 12797 | 0.360 |
Why?
|
| Transfection | 12 | 2006 | 5757 | 0.350 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 428 | 0.350 |
Why?
|
| Genetic Engineering | 4 | 2018 | 935 | 0.350 |
Why?
|
| Growth Differentiation Factor 5 | 2 | 2009 | 37 | 0.350 |
Why?
|
| Cell Membrane | 2 | 2019 | 3657 | 0.340 |
Why?
|
| SOX9 Transcription Factor | 2 | 2020 | 145 | 0.330 |
Why?
|
| Ligaments, Articular | 3 | 2000 | 308 | 0.330 |
Why?
|
| Luciferases | 8 | 2008 | 714 | 0.320 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 163 | 0.320 |
Why?
|
| Disease Models, Animal | 28 | 2025 | 18344 | 0.320 |
Why?
|
| Collagen Type I | 5 | 2021 | 618 | 0.310 |
Why?
|
| Antirheumatic Agents | 3 | 2013 | 1381 | 0.310 |
Why?
|
| Rehabilitation | 2 | 2020 | 129 | 0.300 |
Why?
|
| Protein Kinase C | 6 | 1994 | 1207 | 0.300 |
Why?
|
| Stem Cells | 6 | 2018 | 3537 | 0.300 |
Why?
|
| Collagen Type III | 3 | 2021 | 92 | 0.300 |
Why?
|
| Lanthanoid Series Elements | 1 | 2008 | 17 | 0.300 |
Why?
|
| Autoimmune Diseases | 4 | 2004 | 2256 | 0.290 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 2 | 2004 | 11 | 0.290 |
Why?
|
| Skull | 1 | 2011 | 820 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2014 | 4351 | 0.270 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2009 | 160 | 0.270 |
Why?
|
| Cell Line | 21 | 2017 | 15597 | 0.270 |
Why?
|
| Stem Cell Transplantation | 2 | 2014 | 1596 | 0.270 |
Why?
|
| Immunity, Innate | 1 | 2019 | 3079 | 0.270 |
Why?
|
| Collagenases | 3 | 1997 | 221 | 0.270 |
Why?
|
| Rupture | 8 | 2022 | 444 | 0.260 |
Why?
|
| beta-Galactosidase | 7 | 2002 | 574 | 0.260 |
Why?
|
| Republic of Korea | 2 | 2018 | 591 | 0.260 |
Why?
|
| Wounds and Injuries | 2 | 2017 | 2515 | 0.250 |
Why?
|
| Gelatinases | 11 | 1997 | 93 | 0.250 |
Why?
|
| Adipose Tissue | 4 | 2019 | 3329 | 0.250 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 1801 | 0.250 |
Why?
|
| Growth Differentiation Factors | 3 | 2011 | 99 | 0.240 |
Why?
|
| Knee Joint | 13 | 2003 | 1683 | 0.240 |
Why?
|
| Medial Collateral Ligament, Knee | 3 | 2000 | 24 | 0.240 |
Why?
|
| Spinal Nerve Roots | 2 | 1996 | 122 | 0.230 |
Why?
|
| Fracture Fixation | 4 | 2012 | 370 | 0.230 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2012 | 1608 | 0.230 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2230 | 0.230 |
Why?
|
| Bone Transplantation | 3 | 2016 | 925 | 0.220 |
Why?
|
| Molecular Biology | 2 | 2005 | 573 | 0.220 |
Why?
|
| Cattle | 12 | 2012 | 3819 | 0.220 |
Why?
|
| Bone Marrow Cells | 7 | 2014 | 2414 | 0.220 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2011 | 3514 | 0.220 |
Why?
|
| Male | 64 | 2025 | 364641 | 0.220 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 6 | 2000 | 23 | 0.210 |
Why?
|
| Fibroins | 2 | 2022 | 59 | 0.210 |
Why?
|
| Enzyme Induction | 9 | 2000 | 455 | 0.210 |
Why?
|
| Fibrocartilage | 1 | 2022 | 17 | 0.210 |
Why?
|
| Mice | 37 | 2025 | 82024 | 0.200 |
Why?
|
| Patella | 4 | 2023 | 317 | 0.200 |
Why?
|
| Cell Transplantation | 7 | 2000 | 475 | 0.190 |
Why?
|
| Azo Compounds | 1 | 2021 | 116 | 0.190 |
Why?
|
| Fibrin | 2 | 2022 | 514 | 0.190 |
Why?
|
| Hyaluronic Acid | 1 | 2005 | 484 | 0.190 |
Why?
|
| Immunohistochemistry | 12 | 2019 | 11068 | 0.190 |
Why?
|
| Genetic Markers | 5 | 1999 | 2602 | 0.180 |
Why?
|
| Torsion, Mechanical | 1 | 2020 | 15 | 0.180 |
Why?
|
| Pepsin A | 9 | 1991 | 64 | 0.180 |
Why?
|
| Protein Biosynthesis | 4 | 1997 | 2094 | 0.180 |
Why?
|
| Interleukin-1beta | 3 | 2014 | 1027 | 0.180 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2001 | 491 | 0.180 |
Why?
|
| Progesterone | 1 | 2025 | 752 | 0.180 |
Why?
|
| Peptides | 1 | 2012 | 4354 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 2 | 2005 | 998 | 0.170 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2017 | 161 | 0.170 |
Why?
|
| Cervical Vertebrae | 2 | 1997 | 979 | 0.170 |
Why?
|
| Amino Acid Oxidoreductases | 3 | 1995 | 149 | 0.170 |
Why?
|
| Sports Medicine | 2 | 2000 | 239 | 0.170 |
Why?
|
| Tarsus, Animal | 1 | 1999 | 5 | 0.170 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2000 | 86 | 0.160 |
Why?
|
| Compressive Strength | 2 | 2017 | 159 | 0.160 |
Why?
|
| Tendinopathy | 1 | 2022 | 174 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4937 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1999 | 310 | 0.160 |
Why?
|
| Endopeptidases | 4 | 1988 | 763 | 0.160 |
Why?
|
| Inflammation | 10 | 2019 | 10871 | 0.160 |
Why?
|
| Lumbar Vertebrae | 3 | 1997 | 1885 | 0.160 |
Why?
|
| Bone Matrix | 2 | 1996 | 127 | 0.150 |
Why?
|
| Interleukin-6 | 4 | 1997 | 3228 | 0.150 |
Why?
|
| Trisomy | 1 | 1999 | 260 | 0.150 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2001 | 399 | 0.150 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 3710 | 0.150 |
Why?
|
| Proteins | 6 | 1992 | 6009 | 0.150 |
Why?
|
| Alkaline Phosphatase | 7 | 2020 | 863 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2009 | 1417 | 0.150 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2000 | 384 | 0.150 |
Why?
|
| Biological Factors | 2 | 1989 | 155 | 0.150 |
Why?
|
| Staining and Labeling | 2 | 2021 | 1080 | 0.150 |
Why?
|
| Radius Fractures | 1 | 2024 | 515 | 0.150 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2017 | 97 | 0.150 |
Why?
|
| Paracrine Communication | 1 | 2019 | 278 | 0.150 |
Why?
|
| Athletic Injuries | 2 | 2000 | 1245 | 0.150 |
Why?
|
| Freezing | 1 | 2018 | 311 | 0.140 |
Why?
|
| Interleukin-23 | 1 | 2019 | 202 | 0.140 |
Why?
|
| Faculty, Medical | 2 | 1997 | 1225 | 0.140 |
Why?
|
| Estradiol | 1 | 2025 | 1951 | 0.140 |
Why?
|
| Bony Callus | 3 | 2021 | 41 | 0.140 |
Why?
|
| Human Genome Project | 1 | 1998 | 202 | 0.140 |
Why?
|
| Dendritic Cells | 4 | 2004 | 2745 | 0.140 |
Why?
|
| NF-kappa B | 3 | 2014 | 2493 | 0.140 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 1997 | 81 | 0.140 |
Why?
|
| Serum Albumin, Bovine | 1 | 2017 | 320 | 0.140 |
Why?
|
| Cycloheximide | 4 | 1996 | 341 | 0.140 |
Why?
|
| Cell Survival | 6 | 2017 | 5772 | 0.140 |
Why?
|
| Female | 47 | 2025 | 397113 | 0.140 |
Why?
|
| Cell Culture Techniques | 8 | 2014 | 1667 | 0.130 |
Why?
|
| Menopause | 1 | 2025 | 1656 | 0.130 |
Why?
|
| Academic Medical Centers | 2 | 1997 | 2783 | 0.130 |
Why?
|
| Polyradiculopathy | 1 | 1996 | 23 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2012 | 4748 | 0.130 |
Why?
|
| Macrophages | 3 | 2001 | 5799 | 0.130 |
Why?
|
| Arthritis, Psoriatic | 1 | 2019 | 219 | 0.130 |
Why?
|
| Osteogenesis Imperfecta | 3 | 2005 | 81 | 0.130 |
Why?
|
| Career Mobility | 2 | 1997 | 262 | 0.130 |
Why?
|
| Blotting, Northern | 5 | 2009 | 1550 | 0.130 |
Why?
|
| Hydrogels | 2 | 2020 | 744 | 0.130 |
Why?
|
| Gene Expression Regulation | 13 | 2011 | 11930 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1996 | 287 | 0.130 |
Why?
|
| Stress, Mechanical | 6 | 2012 | 1676 | 0.130 |
Why?
|
| Hypertrophy | 3 | 2020 | 562 | 0.130 |
Why?
|
| Aging | 3 | 2013 | 8744 | 0.120 |
Why?
|
| Rats, Wistar | 7 | 2008 | 1888 | 0.120 |
Why?
|
| Staff Development | 1 | 1997 | 230 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2009 | 4576 | 0.120 |
Why?
|
| Prednisolone | 1 | 1996 | 326 | 0.120 |
Why?
|
| Organizational Objectives | 1 | 1997 | 426 | 0.120 |
Why?
|
| Guanidines | 1 | 1995 | 194 | 0.120 |
Why?
|
| Bone Development | 1 | 2018 | 473 | 0.120 |
Why?
|
| Joint Prosthesis | 2 | 1994 | 251 | 0.120 |
Why?
|
| Cell Movement | 6 | 2014 | 5209 | 0.110 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2019 | 541 | 0.110 |
Why?
|
| Matrix Metalloproteinase 3 | 4 | 1997 | 139 | 0.110 |
Why?
|
| Apoptosis | 7 | 2013 | 9521 | 0.110 |
Why?
|
| Dogs | 6 | 2013 | 3844 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 2 | 1989 | 873 | 0.110 |
Why?
|
| Prosthesis Failure | 2 | 1997 | 1208 | 0.110 |
Why?
|
| Synovitis | 3 | 2005 | 217 | 0.110 |
Why?
|
| Organ Culture Techniques | 4 | 2000 | 794 | 0.110 |
Why?
|
| Treatment Outcome | 13 | 2024 | 65364 | 0.110 |
Why?
|
| Culture Techniques | 4 | 2005 | 530 | 0.100 |
Why?
|
| Moloney murine leukemia virus | 4 | 2001 | 110 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 1335 | 0.100 |
Why?
|
| Glycosaminoglycans | 4 | 2020 | 611 | 0.100 |
Why?
|
| Arginase | 1 | 2013 | 81 | 0.100 |
Why?
|
| DNA, Viral | 1 | 1999 | 2201 | 0.100 |
Why?
|
| Adult | 26 | 2024 | 223583 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 7 | 2014 | 6231 | 0.100 |
Why?
|
| HLA-A2 Antigen | 1 | 2012 | 207 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 2011 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2000 | 1731 | 0.100 |
Why?
|
| Schools, Medical | 2 | 1997 | 882 | 0.100 |
Why?
|
| Genes, Reporter | 4 | 2017 | 1526 | 0.100 |
Why?
|
| External Fixators | 1 | 2012 | 99 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 22381 | 0.100 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 1997 | 262 | 0.100 |
Why?
|
| Cytosol | 2 | 1992 | 887 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2429 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 5 | 2007 | 587 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 9536 | 0.090 |
Why?
|
| In Situ Hybridization | 4 | 2006 | 1892 | 0.090 |
Why?
|
| Nerve Compression Syndromes | 1 | 1993 | 160 | 0.090 |
Why?
|
| Aged | 21 | 2024 | 171446 | 0.090 |
Why?
|
| Peptide Hydrolases | 5 | 1988 | 610 | 0.090 |
Why?
|
| Mice, SCID | 7 | 2009 | 2627 | 0.090 |
Why?
|
| Kinetics | 9 | 2002 | 6328 | 0.090 |
Why?
|
| American Medical Association | 1 | 1991 | 60 | 0.090 |
Why?
|
| Erbium | 2 | 1981 | 13 | 0.090 |
Why?
|
| Social Control, Formal | 1 | 2011 | 107 | 0.090 |
Why?
|
| Hip Prosthesis | 1 | 1997 | 924 | 0.090 |
Why?
|
| Transplantation, Autologous | 4 | 2010 | 2120 | 0.090 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2010 | 8 | 0.090 |
Why?
|
| Fractures, Ununited | 2 | 2010 | 176 | 0.090 |
Why?
|
| Pain | 2 | 2016 | 5100 | 0.090 |
Why?
|
| Prostaglandins E | 2 | 1988 | 166 | 0.090 |
Why?
|
| Clinical Trials, Phase I as Topic | 3 | 2003 | 329 | 0.090 |
Why?
|
| X-Ray Microtomography | 3 | 2021 | 457 | 0.090 |
Why?
|
| Endonucleases | 1 | 2013 | 371 | 0.090 |
Why?
|
| Forecasting | 4 | 2004 | 2945 | 0.090 |
Why?
|
| Phosphorylation | 7 | 2013 | 8314 | 0.080 |
Why?
|
| Gene Targeting | 2 | 2008 | 841 | 0.080 |
Why?
|
| Enzyme Inhibitors | 5 | 1999 | 3726 | 0.080 |
Why?
|
| Tensile Strength | 3 | 2018 | 332 | 0.080 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2009 | 56 | 0.080 |
Why?
|
| Aortic Aneurysm | 2 | 1991 | 649 | 0.080 |
Why?
|
| Tobramycin | 1 | 2009 | 65 | 0.080 |
Why?
|
| Models, Biological | 5 | 2010 | 9493 | 0.080 |
Why?
|
| Rats, Inbred Lew | 3 | 1996 | 1162 | 0.080 |
Why?
|
| Mice, Inbred DBA | 4 | 2012 | 624 | 0.080 |
Why?
|
| Time Factors | 14 | 2013 | 40214 | 0.080 |
Why?
|
| Sciatic Nerve | 1 | 1993 | 628 | 0.080 |
Why?
|
| Plasmids | 3 | 2004 | 2269 | 0.080 |
Why?
|
| Connective Tissue Cells | 1 | 1988 | 50 | 0.080 |
Why?
|
| Tissue Extracts | 1 | 1989 | 139 | 0.080 |
Why?
|
| Cell Extracts | 1 | 1989 | 135 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 4 | 2008 | 2065 | 0.080 |
Why?
|
| Inflammation Mediators | 3 | 2011 | 1892 | 0.080 |
Why?
|
| Culture Media, Conditioned | 2 | 2019 | 521 | 0.080 |
Why?
|
| Aorta, Abdominal | 1 | 1991 | 627 | 0.080 |
Why?
|
| Yttrium | 1 | 2008 | 33 | 0.080 |
Why?
|
| Interleukins | 3 | 2000 | 796 | 0.080 |
Why?
|
| Middle Aged | 26 | 2024 | 223422 | 0.070 |
Why?
|
| Research | 3 | 2005 | 1979 | 0.070 |
Why?
|
| Antigens, Differentiation | 1 | 2011 | 921 | 0.070 |
Why?
|
| Blotting, Western | 5 | 2013 | 5024 | 0.070 |
Why?
|
| Cobalt | 1 | 1988 | 148 | 0.070 |
Why?
|
| Nitrites | 2 | 2000 | 156 | 0.070 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 297 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1071 | 0.070 |
Why?
|
| Cations | 1 | 2008 | 240 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2023 | 3804 | 0.070 |
Why?
|
| Cell Separation | 1 | 1992 | 1729 | 0.070 |
Why?
|
| Nerve Regeneration | 1 | 1993 | 797 | 0.070 |
Why?
|
| DNA | 8 | 2009 | 7213 | 0.070 |
Why?
|
| Prejudice | 1 | 1991 | 574 | 0.070 |
Why?
|
| History, 18th Century | 1 | 2007 | 206 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2001 | 1156 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 1804 | 0.070 |
Why?
|
| Signal Transduction | 7 | 2012 | 23642 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 393 | 0.070 |
Why?
|
| Collagen Type X | 2 | 2020 | 16 | 0.070 |
Why?
|
| Time | 1 | 2008 | 552 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2004 | 195 | 0.060 |
Why?
|
| Commerce | 1 | 2011 | 612 | 0.060 |
Why?
|
| Lentivirus | 3 | 2007 | 518 | 0.060 |
Why?
|
| Feasibility Studies | 6 | 2004 | 5314 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 2271 | 0.060 |
Why?
|
| Health Care Reform | 1 | 1995 | 1256 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 1854 | 0.060 |
Why?
|
| Pressure | 1 | 2009 | 1172 | 0.060 |
Why?
|
| Osteoporosis | 2 | 2005 | 1605 | 0.060 |
Why?
|
| Leadership | 1 | 1995 | 1397 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 1997 | 2219 | 0.060 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 280 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2007 | 348 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2008 | 427 | 0.060 |
Why?
|
| Physicians, Women | 1 | 1991 | 516 | 0.060 |
Why?
|
| Biopsy | 3 | 2017 | 6786 | 0.060 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2005 | 81 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2000 | 514 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 1883 | 0.060 |
Why?
|
| Equipment Design | 2 | 2012 | 3522 | 0.060 |
Why?
|
| Myositis Ossificans | 1 | 2005 | 77 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 59598 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2018 | 687 | 0.060 |
Why?
|
| Spinal Fusion | 2 | 2005 | 1307 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 1991 | 2450 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 3609 | 0.060 |
Why?
|
| Aorta | 1 | 1991 | 2045 | 0.060 |
Why?
|
| Cell Division | 6 | 2000 | 4473 | 0.050 |
Why?
|
| Endocytosis | 2 | 1988 | 955 | 0.050 |
Why?
|
| Radiography | 4 | 2010 | 6983 | 0.050 |
Why?
|
| Base Sequence | 5 | 2009 | 12418 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1836 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 2004 | 455 | 0.050 |
Why?
|
| Elasticity | 2 | 2018 | 656 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2012 | 2322 | 0.050 |
Why?
|
| Culture Media | 3 | 2013 | 898 | 0.050 |
Why?
|
| Intra-Articular Fractures | 1 | 2024 | 73 | 0.050 |
Why?
|
| DNA Damage | 1 | 2013 | 2470 | 0.050 |
Why?
|
| Ligands | 3 | 2006 | 3284 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 1994 | 2908 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2009 | 1572 | 0.050 |
Why?
|
| Random Allocation | 2 | 2018 | 2396 | 0.050 |
Why?
|
| Viruses | 1 | 2006 | 373 | 0.050 |
Why?
|
| Staurosporine | 2 | 1994 | 241 | 0.050 |
Why?
|
| Osteolysis | 1 | 2004 | 274 | 0.050 |
Why?
|
| Chronic Disease | 4 | 2008 | 9384 | 0.050 |
Why?
|
| Interphase | 1 | 2022 | 226 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2007 | 969 | 0.050 |
Why?
|
| Wrist Joint | 1 | 2024 | 267 | 0.050 |
Why?
|
| Autoradiography | 2 | 1995 | 727 | 0.050 |
Why?
|
| Alkaloids | 2 | 1994 | 192 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2004 | 1150 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 1988 | 1276 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1996 | 462 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3140 | 0.050 |
Why?
|
| United States | 6 | 2018 | 73027 | 0.050 |
Why?
|
| Horse Diseases | 1 | 2002 | 55 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2000 | 10757 | 0.050 |
Why?
|
| Rodentia | 1 | 2023 | 262 | 0.050 |
Why?
|
| Genes, Viral | 1 | 2023 | 655 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1997 | 2473 | 0.050 |
Why?
|
| Radiculopathy | 2 | 1996 | 203 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2019 | 3813 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 1991 | 2197 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 9556 | 0.050 |
Why?
|
| Calcium | 5 | 2013 | 5794 | 0.050 |
Why?
|
| Integrin-Binding Sialoprotein | 2 | 2013 | 23 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2009 | 2766 | 0.040 |
Why?
|
| Lactic Acid | 2 | 1998 | 1140 | 0.040 |
Why?
|
| Hand Strength | 1 | 2024 | 466 | 0.040 |
Why?
|
| Nitroso Compounds | 1 | 2000 | 71 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2009 | 2574 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 2020 | 148 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 3 | 1999 | 3409 | 0.040 |
Why?
|
| Phenotype | 5 | 2018 | 16723 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 2000 | 126 | 0.040 |
Why?
|
| Chitin | 1 | 2000 | 34 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1991 | 283 | 0.040 |
Why?
|
| Isoenzymes | 3 | 2000 | 1688 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 3 | 2004 | 2710 | 0.040 |
Why?
|
| Osteotomy | 2 | 2021 | 838 | 0.040 |
Why?
|
| Etidronic Acid | 1 | 1980 | 63 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2004 | 1340 | 0.040 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2000 | 147 | 0.040 |
Why?
|
| Organotechnetium Compounds | 1 | 1980 | 132 | 0.040 |
Why?
|
| Chondroitin Sulfates | 1 | 2000 | 174 | 0.040 |
Why?
|
| Phagocytes | 1 | 1981 | 294 | 0.040 |
Why?
|
| Humerus | 1 | 2001 | 273 | 0.040 |
Why?
|
| Calcimycin | 2 | 1989 | 214 | 0.040 |
Why?
|
| Osteomyelitis | 1 | 2004 | 408 | 0.040 |
Why?
|
| Technetium | 1 | 1980 | 328 | 0.040 |
Why?
|
| Lymphokines | 2 | 1992 | 924 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2001 | 613 | 0.040 |
Why?
|
| Rotator Cuff | 1 | 2022 | 348 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2001 | 825 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 17617 | 0.040 |
Why?
|
| Homicide | 1 | 2002 | 294 | 0.040 |
Why?
|
| Aggrecans | 3 | 2008 | 88 | 0.040 |
Why?
|
| Proline | 2 | 1999 | 455 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 17128 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2019 | 3472 | 0.040 |
Why?
|
| Graft Survival | 1 | 2009 | 3887 | 0.040 |
Why?
|
| Sheep | 2 | 2015 | 1451 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2007 | 990 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 3612 | 0.040 |
Why?
|
| DNA Probes | 2 | 1989 | 542 | 0.040 |
Why?
|
| Cell Aggregation | 2 | 2009 | 238 | 0.040 |
Why?
|
| Magnetics | 1 | 1981 | 597 | 0.040 |
Why?
|
| Keratan Sulfate | 1 | 1997 | 17 | 0.040 |
Why?
|
| Immunity | 2 | 1995 | 1003 | 0.040 |
Why?
|
| Sphingosine | 2 | 1991 | 308 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 2018 | 173 | 0.040 |
Why?
|
| Crime Victims | 1 | 2002 | 348 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 1998 | 324 | 0.040 |
Why?
|
| Biotechnology | 1 | 1999 | 283 | 0.040 |
Why?
|
| Osteopontin | 1 | 2019 | 306 | 0.040 |
Why?
|
| Hospital Restructuring | 1 | 1997 | 11 | 0.040 |
Why?
|
| Prognosis | 3 | 2006 | 29979 | 0.040 |
Why?
|
| Hematoma | 1 | 2022 | 766 | 0.040 |
Why?
|
| Antigens, CD | 2 | 1999 | 4035 | 0.040 |
Why?
|
| Mesoderm | 1 | 2000 | 679 | 0.040 |
Why?
|
| Kanamycin Kinase | 1 | 1997 | 34 | 0.040 |
Why?
|
| Thiourea | 1 | 1997 | 68 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 6071 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2024 | 1597 | 0.030 |
Why?
|
| Collagen Type II | 2 | 2008 | 151 | 0.030 |
Why?
|
| Family Health | 1 | 2002 | 1255 | 0.030 |
Why?
|
| Cyclic AMP | 2 | 1991 | 1471 | 0.030 |
Why?
|
| Citrulline | 1 | 1997 | 107 | 0.030 |
Why?
|
| Arthroplasty, Replacement | 1 | 2000 | 311 | 0.030 |
Why?
|
| Philosophy, Medical | 1 | 1997 | 78 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1998 | 254 | 0.030 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 10264 | 0.030 |
Why?
|
| Drug Synergism | 2 | 1991 | 1760 | 0.030 |
Why?
|
| Knee | 1 | 2018 | 277 | 0.030 |
Why?
|
| Certification | 1 | 2020 | 420 | 0.030 |
Why?
|
| Cell Adhesion | 3 | 2011 | 3096 | 0.030 |
Why?
|
| Neutrophils | 1 | 1989 | 3786 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8637 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 1525 | 0.030 |
Why?
|
| Tyrosine | 1 | 2000 | 1427 | 0.030 |
Why?
|
| Simplexvirus | 2 | 1998 | 805 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 1992 | 3587 | 0.030 |
Why?
|
| Superoxides | 1 | 1997 | 389 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1996 | 188 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 1998 | 437 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1997 | 617 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9614 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 2013 | 13658 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 2018 | 534 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1995 | 43 | 0.030 |
Why?
|
| Animals, Genetically Modified | 2 | 2015 | 1564 | 0.030 |
Why?
|
| Rats, Nude | 2 | 2007 | 105 | 0.030 |
Why?
|
| Actins | 1 | 2002 | 2064 | 0.030 |
Why?
|
| Heme | 1 | 1997 | 316 | 0.030 |
Why?
|
| Safety | 1 | 2000 | 1159 | 0.030 |
Why?
|
| Satellite Viruses | 1 | 2014 | 10 | 0.030 |
Why?
|
| Up-Regulation | 3 | 2000 | 4146 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 812 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2000 | 14718 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 1997 | 22287 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 1994 | 145 | 0.030 |
Why?
|
| Methionine | 1 | 1997 | 573 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 1994 | 150 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 1168 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1997 | 393 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1996 | 866 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3216 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1996 | 245 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 309 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 434 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1996 | 322 | 0.030 |
Why?
|
| Immunoglobulin G | 3 | 2007 | 4564 | 0.030 |
Why?
|
| Osteoarthritis, Knee | 1 | 2025 | 1251 | 0.030 |
Why?
|
| Prostaglandins | 2 | 1994 | 398 | 0.030 |
Why?
|
| Free Radicals | 1 | 1994 | 238 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 1997 | 540 | 0.030 |
Why?
|
| Polyethylene Terephthalates | 1 | 1994 | 112 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1992 | 1750 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2019 | 5902 | 0.030 |
Why?
|
| Tissue Culture Techniques | 2 | 2005 | 290 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2001 | 1361 | 0.030 |
Why?
|
| HIV | 1 | 2001 | 1597 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2003 | 435 | 0.030 |
Why?
|
| Curcumin | 1 | 2014 | 97 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 2510 | 0.030 |
Why?
|
| Diphosphates | 1 | 2013 | 89 | 0.030 |
Why?
|
| Organizational Culture | 1 | 1997 | 513 | 0.030 |
Why?
|
| Lactates | 1 | 1994 | 401 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1996 | 582 | 0.030 |
Why?
|
| Financial Management | 1 | 1995 | 161 | 0.030 |
Why?
|
| Liposomes | 1 | 1997 | 790 | 0.030 |
Why?
|
| Ethylene Oxide | 1 | 1993 | 28 | 0.030 |
Why?
|
| Alginates | 1 | 1994 | 250 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2019 | 924 | 0.030 |
Why?
|
| Freeze Drying | 1 | 1993 | 97 | 0.030 |
Why?
|
| Pyrophosphatases | 1 | 2013 | 142 | 0.030 |
Why?
|
| Nitrates | 1 | 1994 | 260 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 1996 | 465 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 564 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2267 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 205 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2002 | 2173 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1999 | 1802 | 0.020 |
Why?
|
| Alloys | 1 | 2012 | 110 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 1765 | 0.020 |
Why?
|
| Autolysis | 1 | 1991 | 13 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 1991 | 110 | 0.020 |
Why?
|
| Membranes | 1 | 1991 | 164 | 0.020 |
Why?
|
| Hindlimb | 2 | 2003 | 516 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 1758 | 0.020 |
Why?
|
| Biochemical Phenomena | 1 | 1991 | 59 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1997 | 997 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 1135 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1998 | 3740 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1995 | 990 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1995 | 2299 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2013 | 221 | 0.020 |
Why?
|
| Bone Nails | 1 | 2012 | 221 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 5505 | 0.020 |
Why?
|
| Tibial Nerve | 1 | 1990 | 55 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 2953 | 0.020 |
Why?
|
| DNA Primers | 2 | 2009 | 2827 | 0.020 |
Why?
|
| Necrosis | 1 | 1995 | 1616 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1443 | 0.020 |
Why?
|
| Biochemistry | 1 | 1991 | 116 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2024 | 8740 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 892 | 0.020 |
Why?
|
| Calmodulin | 1 | 1991 | 241 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 1752 | 0.020 |
Why?
|
| Social Environment | 1 | 1995 | 1012 | 0.020 |
Why?
|
| Particle Size | 1 | 1994 | 1649 | 0.020 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1989 | 100 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2013 | 2932 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2024 | 12464 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 1992 | 704 | 0.020 |
Why?
|
| Skin | 3 | 2019 | 4503 | 0.020 |
Why?
|
| Teaching | 1 | 1997 | 1171 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 4618 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1989 | 149 | 0.020 |
Why?
|
| Disease Progression | 3 | 2009 | 13665 | 0.020 |
Why?
|
| Titanium | 1 | 2012 | 495 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4289 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2002 | 943 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2009 | 101 | 0.020 |
Why?
|
| Chromatography, Agarose | 1 | 2008 | 29 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1244 | 0.020 |
Why?
|
| Materials Testing | 1 | 2012 | 873 | 0.020 |
Why?
|
| Sulfates | 2 | 2000 | 379 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 4168 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2007 | 2634 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15944 | 0.020 |
Why?
|
| Sepharose | 1 | 2008 | 102 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 2415 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 1988 | 203 | 0.020 |
Why?
|
| Psoriasis | 1 | 1996 | 926 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2002 | 2559 | 0.020 |
Why?
|
| Homeostasis | 1 | 1999 | 3348 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4791 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1991 | 1104 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2008 | 636 | 0.020 |
Why?
|
| Cell Count | 2 | 2002 | 1831 | 0.020 |
Why?
|
| Down-Regulation | 3 | 2000 | 2936 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1997 | 2935 | 0.020 |
Why?
|
| Leukocytes | 3 | 2003 | 2035 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2013 | 911 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 2007 | 88 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1993 | 1057 | 0.020 |
Why?
|
| Karyotyping | 1 | 1988 | 1176 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1993 | 1178 | 0.020 |
Why?
|
| Lectins, C-Type | 2 | 2001 | 594 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 523 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1988 | 425 | 0.020 |
Why?
|
| Curriculum | 1 | 2020 | 3782 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2002 | 2487 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1994 | 3159 | 0.020 |
Why?
|
| Isoxazoles | 1 | 2007 | 233 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 1534 | 0.020 |
Why?
|
| Organ Specificity | 2 | 2002 | 1968 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 1991 | 741 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 1418 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2004 | 12165 | 0.010 |
Why?
|
| Doxycycline | 1 | 2007 | 348 | 0.010 |
Why?
|
| Prevalence | 1 | 2022 | 15867 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10470 | 0.010 |
Why?
|
| Leukemia | 1 | 2013 | 1519 | 0.010 |
Why?
|
| HIV-1 | 1 | 2002 | 6960 | 0.010 |
Why?
|
| Adolescent | 4 | 2008 | 89155 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 1992 | 5798 | 0.010 |
Why?
|
| Binding Sites | 1 | 1993 | 6022 | 0.010 |
Why?
|
| Brain Injuries | 1 | 1996 | 2057 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2002 | 4640 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1984 | 199 | 0.010 |
Why?
|
| Lymphoma | 1 | 2013 | 1897 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1996 | 2165 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 433 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 24314 | 0.010 |
Why?
|
| Tibial Fractures | 1 | 2006 | 276 | 0.010 |
Why?
|
| Communication | 1 | 1997 | 3904 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1995 | 3573 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 361 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1989 | 1610 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 210 | 0.010 |
Why?
|
| Glucuronidase | 1 | 1984 | 205 | 0.010 |
Why?
|
| Neomycin | 1 | 2002 | 94 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2002 | 205 | 0.010 |
Why?
|
| Decorin | 1 | 2001 | 38 | 0.010 |
Why?
|
| Air | 1 | 2002 | 186 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2001 | 92 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 2392 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1996 | 2442 | 0.010 |
Why?
|
| Polyethylene | 1 | 2002 | 187 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1981 | 362 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2001 | 132 | 0.010 |
Why?
|
| Histones | 1 | 1991 | 2600 | 0.010 |
Why?
|
| Transforming Growth Factors | 1 | 2000 | 76 | 0.010 |
Why?
|
| Focus Groups | 1 | 2007 | 1460 | 0.010 |
Why?
|
| International Cooperation | 1 | 2007 | 1434 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2003 | 539 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2564 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2000 | 97 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20757 | 0.010 |
Why?
|
| Arthroscopy | 1 | 2007 | 971 | 0.010 |
Why?
|
| Unemployment | 1 | 2002 | 211 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 610 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2004 | 713 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1986 | 1441 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 1980 | 73 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2003 | 1151 | 0.010 |
Why?
|
| Polystyrenes | 1 | 2000 | 105 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 2000 | 220 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 1538 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2000 | 216 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6314 | 0.010 |
Why?
|
| Anger | 1 | 2002 | 405 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 319 | 0.010 |
Why?
|
| Atrophy | 1 | 2004 | 1646 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 54924 | 0.010 |
Why?
|
| Physicians | 1 | 1997 | 4598 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1999 | 138 | 0.010 |
Why?
|
| Edema | 1 | 2003 | 765 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1999 | 248 | 0.010 |
Why?
|
| Risk Factors | 1 | 2006 | 74936 | 0.010 |
Why?
|
| Hydrostatic Pressure | 1 | 1999 | 98 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1377 | 0.010 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 1999 | 142 | 0.010 |
Why?
|
| Parvovirus | 1 | 1998 | 4 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 1999 | 257 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1999 | 554 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2000 | 598 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1997 | 110 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 1698 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2006 | 997 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8535 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2007 | 1982 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2001 | 555 | 0.010 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1997 | 53 | 0.010 |
Why?
|
| Collateral Ligaments | 1 | 1997 | 34 | 0.010 |
Why?
|
| Retroviridae Infections | 1 | 1997 | 148 | 0.010 |
Why?
|
| Surface Properties | 1 | 2000 | 1165 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 1104 | 0.010 |
Why?
|
| Asthma | 1 | 1996 | 6273 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 18062 | 0.010 |
Why?
|
| Osteocalcin | 1 | 1997 | 275 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2007 | 2028 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 840 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2002 | 881 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1981 | 1622 | 0.010 |
Why?
|
| Microscopy | 1 | 1981 | 909 | 0.010 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 1995 | 49 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 1598 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 1042 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1997 | 254 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2001 | 1076 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7241 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1997 | 573 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 1398 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1995 | 313 | 0.010 |
Why?
|
| Hematocrit | 1 | 1995 | 623 | 0.010 |
Why?
|
| Affect | 1 | 2002 | 1495 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 1542 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1999 | 1082 | 0.010 |
Why?
|
| Shoulder Joint | 1 | 2000 | 745 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6228 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 1992 | 94 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1999 | 3620 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1992 | 171 | 0.010 |
Why?
|
| Stromal Cells | 1 | 1997 | 1336 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1609 | 0.010 |
Why?
|
| Skin Physiological Phenomena | 1 | 1992 | 193 | 0.010 |
Why?
|
| Tibia | 1 | 1997 | 1076 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7470 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1995 | 1266 | 0.010 |
Why?
|
| Polymers | 1 | 1997 | 1627 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 9343 | 0.010 |
Why?
|
| Tretinoin | 1 | 1992 | 524 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2087 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1990 | 443 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20218 | 0.000 |
Why?
|
| Calcinosis | 1 | 1997 | 1481 | 0.000 |
Why?
|
| Oxygen | 1 | 1999 | 4269 | 0.000 |
Why?
|
| Fetus | 1 | 1994 | 1884 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1990 | 1740 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9252 | 0.000 |
Why?
|
| Smoking | 1 | 2002 | 9089 | 0.000 |
Why?
|
| Liver | 1 | 1999 | 7574 | 0.000 |
Why?
|
| Young Adult | 1 | 2008 | 60048 | 0.000 |
Why?
|
| Lung | 1 | 1999 | 10094 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1992 | 7612 | 0.000 |
Why?
|